Telix PharmaceuticalsTLX
13F holders, Q3 2025 (September 30)27holders +6
13new positions
7sold out
1famous investor
$9.57avg. 13F price*
At the end of Q3 2025, 27 institutions reported holding Telix Pharmaceuticals Ltd. (TLX) in their 13F filings, up 6 from Q2 2025. 13 opened new positions and 7 sold out. The largest holders were Millennium Management ($1.9M), Portland Investment Counsel Inc. ($1.2M) and FMR LLC ($1.1M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Telix Pharmaceuticals Ltd.
- CUSIP
- 87961M105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 13 | $5.1M |
| Exits | 7 | $4.9M |
All 13F filers, Q2 2025 → Q3 2025: 678,024 shares bought and 307,317 shares sold, net +370,707 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 27 holders
| Millennium Management | 0.00% | New | 196,741 | $1.9M |
| Portland Investment Counsel Inc. | 0.34% | New | 128,000 | $1.2M |
| FMR LLC | 0.00% | Add +181.5% | 118,479 | $1.1M |
| Lazard Asset Management LLC | 0.00% | New | 114,624 | $1.1M |
| Jane Street Group, LLC | 0.00% | Add +107.9% | 72,992 | $699K |
| Marshall Wace, LLP | 0.00% | New | 48,573 | $465K |
| Private Advisor Group, LLC | 0.00% | Add +67.3% | 42,112 | $403K |
| IHT Wealth Management, LLC | 0.01% | Add +98.0% | 26,208 | $251K |
| JPMorgan Chase & Co. | 0.00% | New | 25,355 | $243K |
| Vanguard Personalized Indexing Management, LLC | 0.00% | Reduce -0.5% | 18,378 | $176K |
| HRT Financial LP | 0.00% | New | 11,641 | $111K |
| UBS Group AG | 0.00% | Reduce -9.1% | 5,565 | $53K |
| Morgan Stanley | 0.00% | Reduce -26.5% | 3,234 | $31K |
| Rhumbline Advisers | 0.00% | Add +117.3% | 2,579 | $25K |
| NewEdge Advisors, LLC | 0.00% | New | 2,400 | $23K |
| Bank of America Corp. | 0.00% | New | 2,150 | $21K |
| State of Wyoming | 0.00% | New | 1,293 | $12K |
| Blue Trust, Inc. | 0.00% | New | 1,206 | $12K |
| Arax Advisory Partners | 0.00% | No change | 1,030 | $10K |
| Osaic Holdings, Inc. | 0.00% | Add +646.7% | 336 | $3K |
| EverSource Wealth Advisors, LLC | 0.00% | Add +86.6% | 125 | $1K |
| Larson Financial Group LLC | 0.00% | New | 53 | $507 |
| Assetmark, Inc. | 0.00% | Add +127.8% | 41 | $392 |
| Transamerica Financial Advisors, LLC | 0.00% | New | 25 | $239 |
| Principal Securities, Inc. | 0.00% | No change | 21 | $201 |
| Farther Finance Advisors, LLC | 0.00% | New | 9 | $86 |
| True Wealth Design, LLC | 0.00% | Reduce -70.0% | 3 | $29 |
"% of holder's portfolio" is TLX's weight in each manager's 13F, not the share of Telix Pharmaceuticals Ltd. the manager owns.